Marijuana could end up being categorized as a Schedule III substance under the Controlled Substances Act (CSA), reported Marijuana Moment, citing a former top Food and Drug Administration (FDA) official.

How? Howard Sklamberg, who chaired the FDA's Marijuana Working Group from 2014 to 2017, said that could be a result of President Joe Biden last year's request for a review of marijuana's classification under federal law as a Schedule I drug, the same classification as heroin and LSD.

There is no doubt that cannabis scheduling will be a burning topic among many other issues at the Benzinga Cannabis Capital Conference in Chicago (Sept. 27-28), where top CEOs, investors, leaders, advocates and politicians will share their thoughts, ideas and experiences.

Sklamberg, who works as an attorney at the firm Arnold & Porter, spoke about a potential marijuana …

Full story available on

A note to our visitors

This website has updated its privacy policy in compliance with changes to European Union data protection law, for all members globally. We’ve also updated our Privacy Policy to give you more information about your rights and responsibilities with respect to your privacy and personal information. Please read this to review the updates about which cookies we use and what information we collect on our site. By continuing to use this site, you are agreeing to our updated privacy policy.